Latest Close
$4.54
Stock Hub
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. Use the sections below to move between chart, technical analysis, fundamentals, and news.
$4.54
-$5.96 (-56.76%)
$99,046,384.00
Healthcare
Biotechnology
buy
$3.35 to $17.94
$15.44
Not available
Not available
-1.40
1.14
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.